Pages
Ads
Categories
- Allergies pills
- Anthelmintics
- Anti Convulsants Pills
- Anti Depressants Pills
- Antibiotics Pills
- AntiViralPill
- Arthritis pills
- Blood Pressure Pills
- Cholesterol Pills
- Diabetes Pills
- Diuretics pills
- eBook download
- Erectile Dysfunction Pills
- Gastrointestinal Pills
- Heartburn Pills
- herbal
- Hypertension pills
- Images pills
- Inflammatory
- Mens Health pills
- Muscle Relaxant Pills
- News
- Other pills
- Pain Relief Pills
- Review prices
- Skin Care Pills
- Stop Smoking Pills
- Uncategorized
- Video about ED pills
- Weight Loss Pills
- Women's Health Drugs
Blogroll
- Acne Treatment Tips
- Acomplia blog
- Advanced whois
- Cialis vs Levitra
- Diet Recipes Blog
- Flexyx A-Z drugs
- Generic Cialis soft tabs
- Home Health Agencies
- Learn How to Overcome Depression
- Safe Net Pharmacy
- Traumatology and Orthopaedics
- Viagra
- Stiefel Receives US FDA Approval of Fabior Foam, 0.1%
- MEDA Announces Dymista Approved by the FDA
- FDA Approves New Orphan Drug Elelyso to Treat a Form of Gaucher Disease
- FDA Approves Levaquin as an Antibacterial Treatment for Plague
- FDA Approves Stendra for Erectile Dysfunction
- FDA Approves Votrient for Advanced Soft Tissue Sarcoma
- Novartis drug Afinitor approved by FDA as first medication to treat patients with non-cancerous kidney tumors associated with TSC
- Victoza Label Updated to Include Data Showing Superior Efficacy When Compared to Januvia
- FDA Approves Amyvid (Florbetapir F 18 Injection) for Use in Patients Being Evaluated for Alzheimer's Disease and Other Causes of Cognitive Decline
- Neupro Approved by U.S. FDA for Parkinson's Disease and Restless Legs Syndrome
Tags
ads
USA approval for once daily Cialis pill
January 9, 2008
Eli Lilly’s once-a-day version of its erectile dysfunction (ED) treatment Cialis (tadalafil) has finally got the go ahead from US regulators, six months after approval in the EU.
The approval means the new formulation is now available to men on the other side of the Atlantic, allowing sufferers of ED 
to attempt sexual activity at any time between doses, rather than during the narrow time frame dictated by the ‘on demand’ version.
According to Lilly, the once daily Cialis formulation is intended for men who anticipate more frequent sexual activity (i.e. twice weekly), and contains a lower dose than the previously approved version that is taken as needed.
The newly approved formulation, aside from offering perhaps a more convenient and attractive option to men, will also be no more taxing on their wallets. According to Lilly, the wholesale pricing for the once-daily Cialis will be comparable to the as-needed formulation, so that patients who currently use two or more pills of the as-needed version should not have higher treatment costs through using the once-daily product.
Gaining EU approval in June last year, the once-a-day product is currently available only in parts of Europe, but introduction to further countries is expected throughout 2008.
No Comments »
No comments yet.
Fatal error: Call to undefined function post_comments_feed_link() in /var/www/viptabs/data/www/news.drugrxus.com/wp-content/themes/apple/comments.php on line 29